ECigs, Inflammation and Oxidative Stress
NCT03823885 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148
Last updated 2023-10-04
Summary
Randomized controlled trial of acute use of electronic cigarette effect on oxidative stress and inflammation.
Conditions
- E-cigarettes, Oxidative Stress, Inflammation
Interventions
- OTHER
-
e-cigarette
use e-cig for 30 minutes
- OTHER
-
empty (-cigarette sham control)
use empty e-cig (sham control)
Sponsors & Collaborators
-
Tobacco Related Disease Research Program
collaborator OTHER -
University of California, Los Angeles
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-02-08
- Primary Completion
- 2023-02-08
- Completion
- 2023-10-01
Countries
- United States
Study Locations
More Related Trials
-
E-cigarette Nicotine Pharmacokinetic Study
NCT03178981 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Study Comparing Nicotine Delivery From E-cigarettes and a Conventional Cigarette in Healthy Subjects
NCT02474849 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Electronic Cigarette Use on the Lungs
NCT02596685 ·Status: COMPLETED ·Phase: NA
-
Effect of Electronic Cigarettes on Platelets, Endothelium and Inflammation
NCT02662075 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Electronic Cigarettes on Nicotine Concentrations
NCT01775787 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of E-Cigarette Aerosol Inhalation
NCT03479203 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
NCT04003805 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes With Nicotine Salt Formulations
NCT03822546 ·Status: COMPLETED ·Phase: NA
-
Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum
NCT02323438 ·Status: COMPLETED ·Phase: NA
-
Characterization of Nicotine Exposure and Urge-to-Smoke Following Use of Electronic and Conventional Cigarettes
NCT02210754 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
NCT02439944 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The Impact of Chronic E-Cigarette Usage on Microvascular Health
NCT06860698 ·Status: RECRUITING
-
e-Cigarettes Versus NRT Gum for Smoking Cessation
NCT01925781 ·Status: TERMINATED ·Phase: PHASE4
-
Methods Project 4: Clinical Trial - Amended
NCT03111537 ·Status: COMPLETED ·Phase: NA
-
Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers
NCT03625986 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539 ·Status: COMPLETED ·Phase: NA
-
ESTxENDS Trial- Substudy on Oxidative Stress Induced by Electronic Nicotine Delivery Systems (ENDS) Measured in EBC
NCT03612453 ·Status: COMPLETED ·Phase: NA
-
Effect of Banning Menthol Flavorant on Cigarette and E-Cigarette Use
NCT03402243 ·Status: COMPLETED ·Phase: NA
-
Electronic Cigarettes in Daily Dependent Smokers
NCT02108626 ·Status: COMPLETED ·Phase: PHASE4
-
The ESTxENDS Trial- Substudy on the Metabolic Effects of Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)
NCT03612336 ·Status: COMPLETED ·Phase: NA
-
E-cigarette Nicotine Study
NCT04709471 ·Status: COMPLETED ·Phase: PHASE2
-
Electronic Cigarettes and Reactivity to Smoking Cues
NCT01782599 ·Status: RECRUITING ·Phase: NA
-
Vascular Effects of a Single Bout of Electronic Cigarette Use
NCT03209661 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy
NCT00882375 ·Status: COMPLETED ·Phase: NA
-
A Trial of Varenicline for E-cigarette Cessation
NCT07040566 ·Status: RECRUITING ·Phase: PHASE2